A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
Clinical trial NCT03854110 · RECRUITING
Trial details
- NCT number
- NCT03854110
- Sponsor
- Persevere Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2027-07-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.